PubRank
Search
About
Hitoshi Zembutsu
Author PubWeight™ 50.67
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.
J Clin Oncol
2010
3.21
2
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy.
Cancer Sci
2008
1.95
3
Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.
Oncogene
2003
1.91
4
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.
Hum Mol Genet
2011
1.91
5
Genome-wide association study of intracranial aneurysm identifies three new risk loci.
Nat Genet
2010
1.86
6
An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.
Cancer Res
2002
1.82
7
A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese.
Nat Genet
2010
1.57
8
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
Clin Cancer Res
2012
1.50
9
Genome-wide association study of pancreatic cancer in Japanese population.
PLoS One
2010
1.50
10
Genome-wide association meta-analysis identifies new endometriosis risk loci.
Nat Genet
2012
1.42
11
A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population.
Nat Genet
2010
1.42
12
Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.
Breast Cancer Res Treat
2011
1.39
13
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Clin Cancer Res
2011
1.26
14
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.
Clin Cancer Res
2012
1.22
15
CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection.
Clin Chem
2009
1.19
16
The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
Oncogene
2002
1.15
17
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia.
Cancer Sci
2008
1.14
18
Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk.
Proc Natl Acad Sci U S A
2011
1.08
19
Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA.
Hum Mol Genet
2012
1.05
20
Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
Cancer Sci
2013
1.00
21
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis.
Mol Cancer Ther
2002
1.00
22
Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters.
Drug Metab Pharmacokinet
2011
0.99
23
Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function.
Stem Cells
2007
0.98
24
Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma.
Oncol Rep
2008
0.98
25
Successful outcomes using combination therapy of interleukin-2 and interferon-alpha for renal cell carcinoma patients with lung metastasis.
Jpn J Clin Oncol
2010
0.95
26
A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.
J Hum Genet
2012
0.94
27
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration.
World J Surg Oncol
2009
0.94
28
Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production.
Proc Jpn Acad Ser B Phys Biol Sci
2011
0.93
29
Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients.
J Hum Genet
2009
0.90
30
Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response.
Pharmacogenet Genomics
2010
0.88
31
Impact of LIMK1, MMP2 and TNF-α variations for intracranial aneurysm in Japanese population.
J Hum Genet
2011
0.87
32
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.
Pharmacogenet Genomics
2012
0.85
33
Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies.
J Hum Genet
2013
0.84
34
Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysis.
Exp Ther Med
2011
0.83
35
Genome-wide gene expression profiles of ovarian carcinoma: Identification of molecular targets for the treatment of ovarian carcinoma.
Mol Med Rep
2011
0.82
36
Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
Genes Chromosomes Cancer
2003
0.82
37
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression.
J Hum Genet
2009
0.81
38
A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.
Breast Cancer Res
2013
0.81
39
Combined immunotherapy with low-dose IL-2 plus IFN-alpha for metastatic renal cell carcinoma: survival benefit for selected patients with lung metastasis and serum sodium level.
Jpn J Clin Oncol
2011
0.80
40
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
J Hepatobiliary Pancreat Surg
2006
0.80
41
Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling.
Exp Ther Med
2010
0.80
42
A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population.
J Hum Genet
2012
0.79
43
Pharmacogenomics toward personalized tamoxifen therapy for breast cancer.
Pharmacogenomics
2015
0.79
44
VAV3 mediates resistance to breast cancer endocrine therapy.
Breast Cancer Res
2014
0.78
45
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients.
Pharmacogenet Genomics
2011
0.77
46
Identification of a set of genes associated with response to interleukin-2 and interferon-α combination therapy for renal cell carcinoma through genome-wide gene expression profiling.
Exp Ther Med
2010
0.77